Latest News

NEURINOX gathers top researchers, patients and industry in an international symposium on innovative concepts for treating neurodegenerative diseases

Neurodegeneration leads to chronic debilitating diseases, including age-related syndromes like Alzheimer’s and Parkinson’s diseases and disorders affecting younger people such as epilepsy and multiple sclerosis. A common disease mechanism in neurodegeneration is inflammation of the brain, also referred to as neuroinflammation. Neurinox, a 5-year international biomedical research project running until the end of 2016, was […]

Read more

Meeting partners and NLS days in Stockholm 9-10 september

Attending one of the largest partnering event in Life Science, these days taking place in Stockholm 9-10 September- 2015. This will be an event not only to meet with research partners and Sponsors for Redoxis preclinical models of autoimmunity, but also initiation of discussion with partners for next call to H2020.

Read more

Tax reduction eligibility for Redoxis services

Redoxis has been approved by the French authorities “Ministère chargé de l’Enseignement supérieur et de la Recherche” eligible for tax reduction for services performed by Redoxis for French research entities. For further information please contact us at service@redoxis.com or directly to Peter Olofsson, CEO or Malin Hutqvist, CSO.    

Read more

RISE – European collaboration with Aston University and University of Erlangen

This month we started the RISE project REDOXIT for Research and Innovation Staff Exchange (RISE) as a collaborative project with Aston University (Birmingham, UK) and University of Erlangen (Germany). This collaborative project will enable R&D collaboration with exchange of research fellows and methodology between the partners for the coming 4 years.

Read more

NEURINOX SYMPOSIUM: INNOVATIVE CONCEPTS FOR TREATING NEURODEGENERATIVE DISEASE

What is the reason behind neuroinflammation involved in the development of neurodegenerative diseases like Amyotrophic lateral sclerosis, Multiple sclerosis and Epilepsy? Could a family of superoxide-generating enzymes called NOX be a key mediator? How can the answer to the above question be used for developing an efficient cure to these diseases? A consortium of European […]

Read more